Oxidative stress as a crucial factor in liver diseases

World Journal of Gastroenterology

Volumn 20, Issue 25, 2014, Pages 8082-8091

  Cichoz Lach, Halina ^a   Michalak, Agata ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Liver disease; Oxidative stress; Redox state

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADVANCED OXIDATION PROTEIN PRODUCT; ALPHA TOCOPHEROL; ANGIOTENSIN II; ASCORBIC ACID; CASPASE 3; COLLAGEN TYPE 1; CYTOCHROME P450 2E1; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; MALONALDEHYDE; MELATONIN; QUERCETIN; REACTIVE OXYGEN METABOLITE; REDOX EFFECTOR FACTOR 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RESVERATROL; SILYMARIN; THIOCTIC ACID; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA; ALDEHYDE DEHYDROGENASE; ANTIOXIDANT; BIOLOGICAL MARKER; EARLY GROWTH RESPONSE FACTOR 1; FREE RADICAL; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REACTIVE NITROGEN SPECIES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR AP 1;

ALCOHOL ABUSE; ALCOHOL LIVER DISEASE; ANTIOXIDANT ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; APOPTOSIS; CELL DEATH; CROSS LINKING; DNA DAMAGE; GENE EXPRESSION; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HUMAN; HYPOXIA; IMMUNITY; INFLAMMATION; LIPID PEROXIDATION; LIVER CELL DAMAGE; LIVER DISEASE; LIVER FIBROSIS; MITOCHONDRIAL PERMEABILITY; NONALCOHOLIC FATTY LIVER; OXIDATION REDUCTION STATE; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REOXYGENATION; REVIEW; SIGNAL TRANSDUCTION; GENE EXPRESSION REGULATION; LIVER CELL CARCINOMA; PATHOGENESIS; ANIMAL; DRUG EFFECTS; LIVER; LIVER DISEASES; METABOLISM; OXIDATION REDUCTION REACTION;

ANIMALS; ANTIOXIDANTS; HUMANS; LIVER; LIVER DISEASES; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84903971446     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i25.8082     Document Type: Review

References (100)

1. Lee J, Giordano S, Zhang J. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J 2012; 441: 523-540 [PMID: 22187934 DOI: 10.1042/ BJ20111451]
2. Apostolova N, Blas-Garcia A, Esplugues JV. Mitochondria sentencing about cellular life and death: a matter of oxidative stress. Curr Pharm Des 2011; 17: 4047-4060 [PMID: 22188454]
3. Edeas M, Attaf D, Mailfert AS, Nasu M, Joubet R. Maillard reaction, mitochondria and oxidative stress: potential role of antioxidants. Pathol Biol (Paris) 2010; 58: 220-225 [PMID: 20031340 DOI: 10.1016/j.patbio.2009.09.011]
4. Majima HJ, Indo HP, Suenaga S, Matsui H, Yen HC, Ozawa T. Mitochondria as possible pharmaceutical targets for the effects of vitamin E and its homologues in oxidative stressrelated diseases. Curr Pharm Des 2011; 17: 2190-2195 [PMID: 21774784]
5. Mao G, Kraus GA, Kim I, Spurlock ME, Bailey TB, Beitz DC. Effect of a mitochondria-targeted vitamin E derivative on mitochondrial alteration and systemic oxidative stress in mice. Br J Nutr 2011; 106: 87-95 [PMID: 21324214 DOI: 10.1017/S0007114510005830]
6. Cesaratto L, Vascotto C, Calligaris S, Tell G. The importance of redox state in liver damage. Ann Hepatol 2004; 3: 86-92 [PMID: 15505592]
7. Wang CH, Wu SB, Wu YT, Wei YH. Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging. Exp Biol Med (Maywood) 2013; 238: 450-460 [PMID: 23856898 DOI: 10.1177/153537021 3493069]
8. Wang B, Van Veldhoven PP, Brees C, Rubio N, Nordgren M, Apanasets O, Kunze M, Baes M, Agostinis P, Fransen M. Mitochondria are targets for peroxisome-derived oxidative stress in cultured mammalian cells. Free Radic Biol Med 2013; 65: 882-894 [PMID: 23988789 DOI: 10.1016/j.freeradbiomed.2 013.08.173]
9. Sinha K, Das J, Pal PB, Sil PC. Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol 2013; 87: 1157-1180 [PMID: 23543009 DOI: 10.1007/s00204-013-1034-4]
10. Lu SC. Antioxidants in the treatment of chronic liver diseases: why is the efficacy evidence so weak in humans? Hepatology 2008; 48: 1359-1361 [PMID: 18697215 DOI: 10.1002/ hep.22463]
11. Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16 [PMID: 21752095 DOI: 10.1111/j.1600-079X.2011.00916.x]
12. Reiter RJ, Tan DX, Mayo JC, Sainz RM, Leon J, Czarnocki Z. Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. Acta Biochim Pol 2003; 50: 1129-1146 [PMID: 14740000]
13. Bubenik GA. Thirty four years since the discovery of gastrointestinal melatonin. J Physiol Pharmacol 2008; 59 Suppl 2: 33-51 [PMID: 18812627]
14. Reiter RJ, Paredes SD, Manchester LC, Tan DX. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009; 44: 175-200 [PMID: 19635037 DOI: 10.1080/10409230903044914]
15. Solís Herruzo JA, Solís Muñoz P. Melatonin and oxidative stress. Rev Esp Enferm Dig 2009; 101: 453-459 [PMID: 19642835]
16. Hardeland R, Pandi-Perumal SR. Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug. Nutr Metab (Lond) 2005; 2: 22 [PMID: 16153306]
17. Kireev R, Bitoun S, Cuesta S, Tejerina A, Ibarrola C, Moreno E, Vara E, Tresguerres JA. Melatonin treatment protects liver of Zucker rats after ischemia/reperfusion by diminishing oxidative stress and apoptosis. Eur J Pharmacol 2013; 701: 185-193 [PMID: 23220161 DOI: 10.1016/j.ejphar.2012.11.038]
18. Hu S, Yin S, Jiang X, Huang D, Shen G. Melatonin protects against alcoholic liver injury by attenuating oxidative stress, inflammatory response, and apoptosis. Eur J Pharmacol 2009; 616: 287-292 [PMID: 19576882 DOI: 10.1016/ j.ejphar.2009.06.044]
19. Rosa DP, Bona S, Simonetto D, Zettler C, Marroni CA, Marroni NP. Melatonin protects the liver and erythrocytes against oxidative stress in cirrhotic rats. Arq Gastroenterol 2010; 47: 72-78 [PMID: 20520979]
20. Natarajan SK, Becker DF. Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stress. Cell Health Cytoskelet 2012; 2012: 11-27 [PMID: 22593641]
21. Li G, Scull C, Ozcan L, Tabas I. NADPH oxidase links endoplasmic reticulum stress, oxidative stress, and PKR activation to induce apoptosis. J Cell Biol 2010; 191: 1113-1125 [PMID: 21135141 DOI: 10.1083/jcb.201006121]
22. Urtasun R, Conde de la Rosa L, Nieto N. Oxidative and nitrosative stress and fibrogenic response. Clin Liver Dis 2008; 12: 769-790, viii [PMID: 18984466 DOI: 10.1016/ j.cld.2008.07.005]
23. Kleniewska P, Piechota-Polanczyk A, Michalski L, Michalska M, Balcerczak E, Zebrowska M, Goraca A. Influence of block of NF-kappa B signaling pathway on oxidative stress in the liver homogenates. Oxid Med Cell Longev 2013; 2013: 308358 [PMID: 23577221 DOI: 10.1155/2013/308358]
24. Li M, Vascotto C, Xu S, Dai N, Qing Y, Zhong Z, Tell G, Wang D. Human AP endonuclease/redox factor APE1/ref-1 modulates mitochondrial function after oxidative stress by regulating the transcriptional activity of NRF1. Free Radic Biol Med 2012; 53: 237-248 [PMID: 22580151 DOI: 10.1016/ j.freeradbiomed.2012.04.002]
25. Aleksunes LM, Manautou JE. Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease. Toxicol Pathol 2007; 35: 459-473 [PMID: 17562481 DOI: 10.1080/01926 230701311344]
26. Collins AR, Gupte AA, Ji R, Ramirez MR, Minze LJ, Liu JZ, Arredondo M, Ren Y, Deng T, Wang J, Lyon CJ, Hsueh WA. Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury. Arterioscler Thromb Vasc Biol 2012; 32: 2839-2846 [PMID: 23023374 DOI: 10.1161/ATVBAHA.112.300345]
27. Shin SM, Yang JH, Ki SH. Role of the Nrf2-ARE pathway in liver diseases. Oxid Med Cell Longev 2013; 2013: 763257 [PMID: 23766860 DOI: 10.1155/2013/763257]
28. Zhu R, Wang Y, Zhang L, Guo Q. Oxidative stress and liver disease. Hepatol Res 2012; 42: 741-749 [PMID: 22489668 DOI: 10.1111/j.1872-034X.2012.00996.x]
29. Muriel P. Role of free radicals in liver diseases. Hepatol Int 2009; 3: 526-536 [PMID: 19941170 DOI: 10.1007/ s12072-009-9158-6]
30. Abd Ellah MR. The role of liver biopsy in detection of hepatic oxidative stress. Vet Med Int 2011; 2011: 613602 [PMID: 21403828 DOI: 10.4061/2011/613602]
31. Diesen DL, Kuo PC. Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitis. J Surg Res 2010; 162: 95-109 [PMID: 20444470 DOI: 10.1016/j.jss.2009.09.019]
32. Cederbaum AI, Lu Y, Wu D. Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol 2009; 83: 519-548 [PMID: 19448996 DOI: 10.1007/s00204-009-0432-0]
33. Ambade A, Mandrekar P. Oxidative stress and inflammation: essential partners in alcoholic liver disease. Int J Hepatol 2012; 2012: 853175 [PMID: 22500241 DOI: 10.1155/2012/853175]
34. De Minicis S, Brenner DA. Oxidative stress in alcoholic liver disease: role of NADPH oxidase complex. J Gastroenterol Hepatol 2008; 23 Suppl 1: S98-103 [PMID: 18336675 DOI: 10.1111/j.1440-1746.2007.05277.x]
35. Sid B, Verrax J, Calderon PB. Role of oxidative stress in the pathogenesis of alcohol-induced liver disease. Free Radic Res 2013; 47: 894-904 [PMID: 23800214 DOI: 10.3109/10715762.20 13.819428]
36. Bailey SM, Cunningham CC. Contribution of mitochondria to oxidative stress associated with alcoholic liver disease. Free Radic Biol Med 2002; 32: 11-16 [PMID: 11755312]
37. Wu D, Cederbaum AI. Oxidative stress and alcoholic liver disease. Semin Liver Dis 2009; 29: 141-154 [PMID: 19387914 DOI: 10.1055/s-0029-1214370]
38. Roskams T, Yang SQ, Koteish A, Durnez A, DeVos R, Huang X, Achten R, Verslype C, Diehl AM. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 2003; 163: 1301-1311 [PMID: 14507639]
39. Podrini C, Borghesan M, Greco A, Pazienza V, Mazzoccoli G, Vinciguerra M. Redox homeostasis and epigenetics in nonalcoholic fatty liver disease (NAFLD). Curr Pharm Des 2013; 19: 2737-2746 [PMID: 23092327]
40. Ucar F, Sezer S, Erdogan S, Akyol S, Armutcu F, Akyol O. The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis. Redox Rep 2013; 18: 127-133 [PMID: 23743495 DOI: 10.1179/1351000213Y.0000000050]
41. Musso G, Gambino R, Cassader M. Non-alcoholic fatty liver disease from pathogenesis to management: an update. Obes Rev 2010; 11: 430-445 [PMID: 19845871 DOI: 10.1111/j.1467-789X.2009.00657.x]
42. Koek GH, Liedorp PR, Bast A. The role of oxidative stress in non-alcoholic steatohepatitis. Clin Chim Acta 2011; 412: 1297-1305 [PMID: 21514287 DOI: 10.1016/j.cca.2011.04.013]
43. Brunt EM, Kleiner DE, Wilson LA, Unalp A, Behling CE, Lavine JE, Neuschwander-Tetri BA. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. Hepatology 2009; 49: 809-820 [PMID: 19142989 DOI: 10.1002/hep.22724]
44. Gawrieh S, Opara EC, Koch TR. Oxidative stress in nonalcoholic fatty liver disease: pathogenesis and antioxidant therapies. J Investig Med 2004; 52: 506-514 [PMID: 15682682]
45. Matthew Morris E, Fletcher JA, Thyfault JP, Rector RS. The role of angiotensin II in nonalcoholic steatohepatitis. Mol Cell Endocrinol 2013; 378: 29-40 [PMID: 22579612 DOI: 10.1016/ j.mce.2012.04.013]
46. Wei Y, Clark SE, Morris EM, Thyfault JP, Uptergrove GM, Whaley-Connell AT, Ferrario CM, Sowers JR, Ibdah JA. Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats. J Hepatol 2008; 49: 417-428 [PMID: 18486983 DOI: 10.1016/j.jhep.2008.03.018]
47. Patrick L. Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. Altern Med Rev 2002; 7: 276-291 [PMID: 12197781]
48. Santos JC, Valentim IB, de Araújo OR, Ataide Tda R, Goulart MO. Development of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end products. Int J Mol Sci 2013; 14: 19846-19866 [PMID: 24084729 DOI: 10.3390/ijms141019846]
49. Kathirvel E, Chen P, Morgan K, French SW, Morgan TR. Oxidative stress and regulation of anti-oxidant enzymes in cytochrome P4502E1 transgenic mouse model of non-alcoholic fatty liver. J Gastroenterol Hepatol 2010; 25: 1136-1143 [PMID: 20594230 DOI: 10.1111/j.1440-1746.2009.06196.x]
50. Oliveira CP, Coelho AM, Barbeiro HV, Lima VM, Soriano F, Ribeiro C, Molan NA, Alves VA, Souza HP, Machado MC, Carrilho FJ. Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease. Braz J Med Biol Res 2006; 39: 189-194 [PMID: 16470305]
51. Videla LA, Rodrigo R, Araya J, Poniachik J. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. Free Radic Biol Med 2004; 37: 1499-1507 [PMID: 15454290]
52. Rolo AP, Teodoro JS, Palmeira CM. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic Biol Med 2012; 52: 59-69 [PMID: 22064361 DOI: 10.1016/j.free radbiomed.2011.10.003]
53. Videla LA. Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms. World J Hepatol 2009; 1: 72-78 [PMID: 21160968 DOI: 10.4254/wjh.v1.i1.72]
54. Sumida Y, Niki E, Naito Y, Yoshikawa T. Involvement of free radicals and oxidative stress in NAFLD/NASH. Free Radic Res 2013; 47: 869-880 [PMID: 24004441 DOI: 10.3109/10 715762.2013.837577]
55. Wei Y, Clark SE, Thyfault JP, Uptergrove GM, Li W, Whaley-Connell AT, Ferrario CM, Sowers JR, Ibdah JA. Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats. Am J Pathol 2009; 174: 1329-1337 [PMID: 19246643 DOI: 10.2353/ajpath.2009.080697]
56. Skowrońska M, Albrecht J. Oxidative and nitrosative stress in ammonia neurotoxicity. Neurochem Int 2013; 62: 731-737 [PMID: 23142151 DOI: 10.1016/j.neuint.2012.10.013]
57. Arias JL, Aller MA, Sánchez-Patan F, Arias J. The inflammatory bases of hepatic encephalopathy. Eur J Gastroenterol Hepatol 2006; 18: 1297-1310 [PMID: 17099380]
58. Lachmann V, Görg B, Bidmon HJ, Keitel V, Häussinger D. Precipitants of hepatic encephalopathy induce rapid astrocyte swelling in an oxidative stress dependent manner. Arch Biochem Biophys 2013; 536: 143-151 [PMID: 23707757 DOI: 10.1016/j.abb.2013.05.004]
59. Görg B, Schliess F, Häussinger D. Osmotic and oxidative/ nitrosative stress in ammonia toxicity and hepatic encephalopathy. Arch Biochem Biophys 2013; 536: 158-163 [PMID: 23567841 DOI: 10.1016/j.abb.2013.03.010]
60. Seyan AS, Hughes RD, Shawcross DL. Changing face of hepatic encephalopathy: role of inflammation and oxidative stress. World J Gastroenterol 2010; 16: 3347-3357 [PMID: 20632436]
61. Bosoi CR, Yang X, Huynh J, Parent-Robitaille C, Jiang W, Tremblay M, Rose CF. Systemic oxidative stress is implicated in the pathogenesis of brain edema in rats with chronic liver failure. Free Radic Biol Med 2012; 52: 1228-1235 [PMID: 22300646 DOI: 10.1016/j.freeradbiomed.2012.01.006]
62. Jayakumar AR, Tong XY, Ospel J, Norenberg MD. Role of cerebral endothelial cells in the astrocyte swelling and brain edema associated with acute hepatic encephalopathy. Neuroscience 2012; 218: 305-316 [PMID: 22609932 DOI: 10.1016/ j.neuroscience.2012.05.006]
63. Lemberg A, Fernández MA. Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress. Ann Hepatol 2009; 8: 95-102 [PMID: 19502650]
64. Bosoi CR, Rose CF. Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy. Metab Brain Dis 2013; 28: 175-178 [PMID: 23124921 DOI: 10.1007/ s11011-012-9351-5]
65. Görg B, Qvartskhava N, Bidmon HJ, Palomero-Gallagher N, Kircheis G, Zilles K, Häussinger D. Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy. Hepatology 2010; 52: 256-265 [PMID: 20583283 DOI: 10.1002/hep.23656]
66. Häussinger D, Görg B. Interaction of oxidative stress, astrocyte swelling and cerebral ammonia toxicity. Curr Opin Clin Nutr Metab Care 2010; 13: 87-92 [PMID: 19904201 DOI: 10.1097/MCO.0b013e328333b829]
67. Cichoż-Lach H, Michalak A. Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy. World J Gastroenterol 2013; 19: 26-34 [PMID: 23326159 DOI: 10.3748/wjg.v19.i1.26]
68. Bemeur C, Desjardins P, Butterworth RF. Evidence for oxidative/ nitrosative stress in the pathogenesis of hepatic encephalopathy. Metab Brain Dis 2010; 25: 3-9 [PMID: 20195724 DOI: 10.1007/s11011-010-9177-y]
69. Norenberg MD, Jayakumar AR, Rama Rao KV. Oxidative stress in the pathogenesis of hepatic encephalopathy. Metab Brain Dis 2004; 19: 313-329 [PMID: 15554424]
70. Novo E, Parola M. The role of redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 2012; 5: S4 [PMID: 23259696]
71. Clichici S, Catoi C, Mocan T, Filip A, Login C, Nagy A, Daicoviciu D, Decea N, Gherman C, Moldovan R, Muresan A. Non-invasive oxidative stress markers for liver fibrosis development in the evolution of toxic hepatitis. Acta Physiol Hung 2011; 98: 195-204 [PMID: 21616778 DOI: 10.1556/ APhysiol.98.2011.2.11]
72. De Minicis S, Marzioni M, Saccomanno S, Rychlicki C, Agostinelli L, Trozzi L, Benedetti A, Svegliati-Baroni G. Cellular and molecular mechanisms of hepatic fibrogenesis leading to liver cancer. Transl Gastrointest Cancer 2012; 1: 88-94 [DOI: 10.3978/j.issn.2224-4778.2011.12.05]
73. Diesen DL, Kuo PC. Nitric oxide and redox regulation in the liver: part II. Redox biology in pathologic hepatocytes and implications for intervention. J Surg Res 2011; 167: 96-112 [PMID: 20400112 DOI: 10.1016/j.jss.2009.10.006]
74. Paik YH, Kim J, Aoyama T, De Minicis S, Bataller R, Brenner DA. Role of NADPH oxidases in liver fibrosis. Antioxid Redox Signal 2014; 20: 2854-2872 [PMID: 24040957]
75. Paik YH, Brenner DA. NADPH oxidase mediated oxidative stress in hepatic fibrogenesis. Korean J Hepatol 2011; 17: 251-257 [PMID: 22310788 DOI: 10.3350/kjhep.2011.17.4.251]
76. Geetha A, Lakshmi Priya MD, Jeyachristy SA, Surendran R. Level of oxidative stress in the red blood cells of patients with liver cirrhosis. Indian J Med Res 2007; 126: 204-210 [PMID: 18037714]
77. Koike K. Pathogenesis of HCV-associated HCC: Dual-pass carcinogenesis through activation of oxidative stress and intracellular signaling. Hepatol Res 2007; 37 Suppl 2: S115-S120 [PMID: 17877471]
78. Choi J. Oxidative stress, endogenous antioxidants, alcohol, and hepatitis C: pathogenic interactions and therapeutic considerations. Free Radic Biol Med 2012; 52: 1135-1150 [PMID: 22306508 DOI: 10.1016/j.freeradbiomed.2012.01.008]
79. Ivanov AV, Bartosch B, Smirnova OA, Isaguliants MG, Kochetkov SN. HCV and oxidative stress in the liver. Viruses 2013; 5: 439-469 [PMID: 23358390 DOI: 10.3390/v5020439[PMID:]
80. Yen HH, Shih KL, Lin TT, Su WW, Soon MS, Liu CS. Decreased mitochondrial deoxyribonucleic acid and increased oxidative damage in chronic hepatitis C. World J Gastroenterol 2012; 18: 5084-5089 [PMID: 23049218 DOI: 10.3748/wjg.v18. i36.5084]
81. Simula MP, De Re V. Hepatitis C virus-induced oxidative stress and mitochondrial dysfunction: a focus on recent advances in proteomics. Proteomics Clin Appl 2010; 4: 782-793 [PMID: 21137022 DOI: 10.1002/prca.201000049]
82. Brault C, Levy PL, Bartosch B. Hepatitis C virus-induced mitochondrial dysfunctions. Viruses 2013; 5: 954-980 [PMID: 23518579 DOI: 10.3390/v5030954]
83. Piccoli C, Scrima R, Quarato G, D'Aprile A, Ripoli M, Lecce L, Boffoli D, Moradpour D, Capitanio N. Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress. Hepatology 2007; 46: 58-65 [PMID: 17567832]
84. Piccoli C, Quarato G, Ripoli M, D'Aprile A, Scrima R, Cela O, Boffoli D, Moradpour D, Capitanio N. HCV infection induces mitochondrial bioenergetic unbalance: causes and effects. Biochim Biophys Acta 2009; 1787: 539-546 [PMID: 19094961 DOI: 10.1016/j.bbabio.2008.11.008]
85. Joyce MA, Walters KA, Lamb SE, Yeh MM, Zhu LF, Kneteman N, Doyle JS, Katze MG, Tyrrell DL. HCV induces oxidative and ER stress, and sensitizes infected cells to apoptosis in SCID/Alb-uPA mice. PLoS Pathog 2009; 5: e1000291 [PMID: 19242562 DOI: 10.1371/journal.ppat.1000291]
86. González-Gallego J, García-Mediavilla MV, Sánchez-Campos S. Hepatitis C virus, oxidative stress and steatosis: current status and perspectives. Curr Mol Med 2011; 11: 373-390 [PMID: 21568933]
87. Fierbinţeanu-Braticevici C, Mohora M, Creţoiu D, Creţoiu S, Petrişor A, Usvat R, Ion DA. Role of oxidative stress in the pathogenesis of chronic hepatitis C (CHC). Rom J Morphol Embryol 2009; 50: 407-412 [PMID: 19690766]
88. Liu H, Han T, Tian J, Zhu ZY, Liu Y, Li Y, Xiao SX, Li Y, Feng YY. Monitoring oxidative stress in acute-on-chronic liver failure by advanced oxidation protein products. Hepatol Res 2012; 42: 171-180 [PMID: 22103276 DOI: 10.1111/j.1872-034X.2011.00911.x]
89. Ozeni{dotless}rler S, Erkan G, Gülbahar O, Bostankolu O, Ozbaş Demi{dotless}rel O, Bi{dotless}lgi{dotless}han A, Akyol G. Serum levels of advanced oxidation protein products, malonyldialdehyde, and total radical trapping antioxidant parameter in patients with chronic hepatitis C. Turk J Gastroenterol 2011; 22: 47-53 [PMID: 21480111 DOI: 10.4318/tjg.2011.0156]
90. Zuwała-Jagiełło J, Pazgan-Simon M, Simon K, Warwas M. Advanced oxidation protein products and inflammatory markers in liver cirrhosis: a comparison between alcoholrelated and HCV-related cirrhosis. Acta Biochim Pol 2011; 58: 59-65 [PMID: 21403920]
91. Elias-Miró M, Jiménez-Castro MB, Rodés J, Peralta C. Current knowledge on oxidative stress in hepatic ischemia/reperfusion. Free Radic Res 2013; 47: 555-568 [PMID: 23738581 DOI: 10.3109/10715762.2013.811721]
92. Bhogal RH, Curbishley SM, Weston CJ, Adams DH, Afford SC. Reactive oxygen species mediate human hepatocyte injury during hypoxia/reoxygenation. Liver Transpl 2010; 16: 1303-1313 [PMID: 21031546 DOI: 10.1002/lt.22157]
93. Mukhopadhyay P, Horváth B, Zsengellėr Z, Bátkai S, Cao Z, Kechrid M, Holovac E, Erdėlyi K, Tanchian G, Liaudet L, Stillman IE, Joseph J, Kalyanaraman B, Pacher P. Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: therapeutic potential of mitochondrially targeted antioxidants. Free Radic Biol Med 2012; 53: 1123-1138 [PMID: 22683818 DOI: 10.1016/j.freeradbiomed.2012.05.036]
94. Reiniers MJ, van Golen RF, van Gulik TM, Heger M. Reactive Oxygen and Nitrogen Species in Steatotic Hepatocytes: A Molecular Perspective on the Pathophysiology of Ischemia-Reperfusion Injury in the Fatty Liver. Antioxid Redox Signal 2014; Epub ahead of print [PMID: 24294945]
95. Osawa T. Nephroprotective and hepatoprotective effects of curcuminoids. Adv Exp Med Biol 2007; 595: 407-423 [PMID: 17569222]
96. Esrefoglu M. Oxidative stress and benefits of antioxidant agents in acute and chronic hepatitis. Hepat Mon 2012; 12: 160-167 [PMID: 22550523 DOI: 10.5812/hepatmon.837]
97. Ha HL, Shin HJ, Feitelson MA, Yu DY. Oxidative stress and antioxidants in hepatic pathogenesis. World J Gastroenterol 2010; 16: 6035-6043 [PMID: 21182217]
98. Sumida Y, Naito Y, Tanaka S, Sakai K, Inada Y, Taketani H, Kanemasa K, Yasui K, Itoh Y, Okanoue T, Yoshikawa T. Long-term (> =2 yr) efficacy of vitamin E for non-alcoholic steatohepatitis. Hepatogastroenterology 2013; 60: 1445-1450 [PMID: 23933938 DOI: 10.5754/hge11421.]
99. Al-Busafi SA, Bhat M, Wong P, Ghali P, Deschenes M. Antioxidant therapy in nonalcoholic steatohepatitis. Hepat Res Treat 2012; 2012: 947575 [PMID: 23227320 DOI: 10.1155/2012/947575]
100. Singal AK, Jampana SC, Weinman SA. Antioxidants as therapeutic agents for liver disease. Liver Int 2011; 31: 1432-1448 [PMID: 22093324 DOI: 10.1111/j.1478-3231.2011.02604.x]